NFKB1 and cardiovascular disorder: By contrast, adiponectin, another adipokine, which is negatively associated with fat mass and abdominal fat, can inhibit the activation of NF-κB, regulate glycemic balance and fatty acid utilization, and protect against inflammation and cardiovascular diseases [39,40].